Who has invested in NewBiologix?

Recipharm A/S are named among the investors backing NewBiologix.

NewBiologix Funding: $50M Raised, Series A (2023)

NewBiologix funding overview

NewBiologix is based in Lausanne, Switzerland. NewBiologix has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2023. The round record for NewBiologix runs through 2023; nothing later has been disclosed. Investors on record include Recipharm A/S.

NewBiologix at a glance

Total raised: $50M
Latest round: Series A
Latest round date: May 2023
Headquarters: Lausanne, Switzerland
Notable investors: Recipharm A/S

Frequently asked about NewBiologix funding

How much has NewBiologix raised?: NewBiologix has raised $50M in total disclosed funding across the rounds on record.
Who has invested in NewBiologix?: Recipharm A/S are named among the investors backing NewBiologix.
What was the latest NewBiologix funding round?: The most recent disclosed round is a Series A, announced in May 2023.
Where is NewBiologix based?: NewBiologix is based in Lausanne, Switzerland.
When did NewBiologix last raise?: The last disclosed NewBiologix round closed in May 2023 at Series A.

Round data for NewBiologix is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Lausanne and backer lists below.

NewBiologix Funding: $50M Raised, Series A (2023)

NewBiologix funding overview

NewBiologix at a glance

Frequently asked about NewBiologix funding

Companies related to NewBiologix (18)

Browse related funding lists (3)